Sareum Holdings plc (SAR.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 05:08PM GMT
| Previous close | 105.00 |
| Open | 105.00 |
| Bid | 105.00 x 0 |
| Ask | 120.00 x 0 |
| Day's range | 103.89 - 118.90 |
| 52-week range | 55.10 - 345.00 |
| Volume | |
| Avg. volume | 133,227 |
| Market cap | 82.194M |
| Beta (5Y monthly) | -0.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.70 |
| Earnings date | 20 Feb 2023 - 24 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Sareum Holdings (LON:SAR) Is In A Good Position To Deliver On Growth Plans
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
- Globe Newswire
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update
Sareum Holdings PLC (“Sareum” or the “Company”) Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update Clinical Trial Authorisation application for a Phase 1a/b clinical trial with SDC-1801 submitted to the UK Medicines and Healthcare Products Regulatory AgencySareum has made significant progress advancing SDC-1801 towards clinical development and plans to initiate Phase 1 clinical trials in 2022, with
- Simply Wall St.
What Is The Ownership Structure Like For Sareum Holdings plc (LON:SAR)?
The big shareholder groups in Sareum Holdings plc ( LON:SAR ) have power over the company. Generally speaking, as a...
© 2023 Yahoo. All rights reserved.
